Gene · 81620
Papers2,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Antiparasitic agent emodepside exerts cytotoxicity in human corneal stromal cells by blocking the interaction between mini-chromosome maintenance 6 protein (MCM6) and chromatin licensing and DNA replication factor 1 (CDT1). | Toxicology | 2026 | 41203057 | PubTator, text mining | PubMed |
| Identifying Barriers and Pathways to Care Among College Students at Risk of or Diagnosed with First Episode Psychosis. | Psychiatry Int (Basel) | 2025 | 41768392 | PubTator, text mining | PubMed |
| A deep learning approach for time-consistent cell cycle phase prediction from microscopy data. | PLoS Comput Biol | 2025 | 41379930 | PubTator, text mining | PubMed |
| Benchmark for simple and complex genome inversions. | bioRxiv | 2025 | 41377520 | PubTator, text mining | PubMed |
| Geminin inhibits DNA replication licensing by sterically blocking CDT1-MCM2 interactions. | Nat Commun | 2025 | 41365879 | PubTator, text mining | PubMed |
| Dynamic sensor selection for biomarker discovery. | Proc Natl Acad Sci U S A | 2025 | 41055977 | PubTator, text mining | PubMed |
| TRIM21 promotes colorectal cancer development through regulating DNA replication by TCF3/MCM2/5 axis. | Cell Death Discov | 2025 | 40998798 | PubTator, text mining | PubMed |
| Temporal control of human DNA replication licensing by CDK4/6-RB signalling and chemical genetics. | Nat Commun | 2025 | 40940326 | PubTator, text mining | PubMed |
| SLFN11, far from being limited to responding to cancer DNA damage. | Clin Exp Med | 2025 | 40856812 | PubTator, text mining | PubMed |
| High-throughput investigation of cyclin docking interactions reveals the complexity of motif binding determinants. | Nat Commun | 2025 | 40817109 | PubTator, text mining | PubMed |
| Reproductive Toxicity Effects of Phthalates Based on the Hypothalamic-Pituitary-Gonadal Axis: A Priority Control List Construction from Theoretical Methods. | Int J Mol Sci | 2025 | 40806518 | PubTator, text mining | PubMed |
| Integrative analysis of CRISPR screening and gene expression data identifies a three-gene prognostic model associated with immune microenvironment in neuroblastoma. | Transl Cancer Res | 2025 | 40792157 | PubTator, text mining | PubMed |
| SLFN11: a pan-cancer biomarker for DNA-targeted drugs sensitivity and therapeutic strategy guidance. | Front Oncol | 2025 | 40766331 | PubTator, text mining | PubMed |
| Identification of hub genes as potential diagnostic biomarkers for cervical cancer: A bioinformatic approach. | Comput Biol Chem | 2025 | 40763562 | PubTator, text mining | PubMed |
| New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy. | J Pharm Anal | 2025 | 40747342 | PubTator, text mining | PubMed |
| Epigenome and three-dimensional genome architecture remodeling during NDM29-mediated retro-transformation of neuroblastoma cells. | PLoS One | 2025 | 40743051 | PubTator, text mining | PubMed |
| Mitochondria-derived nuclear ATP surge protects against confinement-induced proliferation defects. | Nat Commun | 2025 | 40738970 | PubTator, text mining | PubMed |
| Pharmacological CLK inhibition disrupts SR protein function and RNA splicing blocking cell growth and migration in TNBC. | Breast Cancer Res | 2025 | 40731028 | PubTator, text mining | PubMed |
| VOPP1, a determinant of the sensitivity of non-small cell lung cancer cells to NAE inhibitors. | Eur J Pharmacol | 2025 | 40651787 | PubTator, text mining | PubMed |
| KLHL5 Contributes to Colorectal Cancer Cell Survival by Promoting Cell Cycle Progression and Suppressing Apoptotic Cell Death. | Cancer Sci | 2025 | 40590665 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81620/papers?page=2